DocGo Inc. (DCGO) P/E Ratio History
Historical price-to-earnings valuation from 2021 to 2024
Loading P/E history...
DCGO Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, DocGo Inc. (DCGO) trades at a price-to-earnings ratio of -0.3x, with a stock price of $0.63 and trailing twelve-month earnings per share of $-999999.00.
The current P/E is 101% below its 5-year average of 44.8x. Over the past five years, DCGO's P/E has ranged from a low of 11.1x to a high of 170.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, DCGO trades at a 102% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, DCGO trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DCGO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DCGO P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $124M | 24.6 | - | +125%Best | |
| $868M | 129.5 | - | - | |
| $7B | 50.3 | - | -4% | |
| $5B | 23.5 | 0.30Best | +54% | |
| $3B | 13.5 | - | -71% | |
| $569M | 12.3Lowest | - | -15% | |
| $149B | 153.3 | - | -11% | |
| $336B | 27.9 | - | -15% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
DCGO Historical P/E Data (2021–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q4 | $4.24 | $0.18 | 23.4x | -48% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $3.32 | $0.29 | 11.6x | -74% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $3.09 | $0.28 | 11.1x | -75% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $4.04 | $0.20 | 20.3x | -55% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $5.59 | $0.07 | 86.0x | +92% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $5.33 | $0.07 | 75.1x | +67% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $9.37 | $0.06 | 170.4x | +280% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $8.65 | $0.18 | 46.9x | +5% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $7.07 | $0.31 | 22.8x | -49% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $9.92 | $0.43 | 23.0x | -49% |
| FY2022 Q2 | $7.14 | $0.44 | 16.3x | -64% | |
| FY2022 Q1 | $9.25 | $0.31 | 29.8x | -34% |
Average P/E for displayed period: 44.8x
See DCGO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DCGO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DCGO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDCGO — Frequently Asked Questions
Quick answers to the most common questions about buying DCGO stock.
Is DCGO stock overvalued or undervalued?
DCGO trades at -0.3x P/E, below its 5-year average of 44.8x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does DCGO's valuation compare to peers?
DocGo Inc. P/E of -0.3x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is DCGO's PEG ratio?
DCGO PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2021-2024.